Peptron, Inc. (087010.KQ)
KRW 98300.0
(-1.99%)
KRW 98300.0
(-1.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 172.18 Million KRW | -78.83% |
| 2022 | 813.52 Million KRW | 15.4% |
| 2021 | 704.94 Million KRW | 573.77% |
| 2020 | 104.62 Million KRW | 334.96% |
| 2019 | 24.05 Million KRW | -4.12% |
| 2018 | 25.08 Million KRW | -94.84% |
| 2017 | 485.9 Million KRW | 104.81% |
| 2016 | 237.24 Million KRW | 533.94% |
| 2015 | 37.42 Million KRW | -74.45% |
| 2014 | 146.49 Million KRW | 386.71% |
| 2013 | 30.09 Million KRW | -8.34% |
| 2012 | 32.83 Million KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 337.31 Million KRW | 95.9% |
| 2024 Q2 | 217.89 Million KRW | -35.4% |
| 2023 Q3 | 296.62 Million KRW | 135.25% |
| 2023 Q1 | 272.86 Million KRW | -66.46% |
| 2023 Q2 | 126.08 Million KRW | -53.79% |
| 2023 FY | 172.18 Million KRW | -78.83% |
| 2023 Q4 | 172.18 Million KRW | -41.95% |
| 2022 Q4 | 813.52 Million KRW | 298.44% |
| 2022 Q3 | 204.17 Million KRW | -72.38% |
| 2022 Q2 | 739.28 Million KRW | 27.77% |
| 2022 FY | 813.52 Million KRW | 15.4% |
| 2022 Q1 | 578.58 Million KRW | -17.92% |
| 2021 Q4 | 704.94 Million KRW | 292.77% |
| 2021 FY | 704.94 Million KRW | 573.77% |
| 2021 Q2 | 53.29 Million KRW | -80.02% |
| 2021 Q3 | 179.48 Million KRW | 236.74% |
| 2021 Q1 | 266.75 Million KRW | 154.95% |
| 2020 Q1 | 118.19 Million KRW | 391.37% |
| 2020 Q4 | 104.62 Million KRW | -63.86% |
| 2020 Q2 | 209.66 Million KRW | 77.38% |
| 2020 Q3 | 289.54 Million KRW | 38.1% |
| 2020 FY | 104.62 Million KRW | 334.96% |
| 2019 Q3 | 35 Million KRW | -25.78% |
| 2019 Q2 | 47.15 Million KRW | -15.91% |
| 2019 Q1 | 56.08 Million KRW | 123.53% |
| 2019 FY | 24.05 Million KRW | -4.12% |
| 2019 Q4 | 24.05 Million KRW | -31.28% |
| 2018 Q1 | 303.12 Million KRW | -37.62% |
| 2018 FY | 25.08 Million KRW | -94.84% |
| 2018 Q3 | 127.84 Million KRW | -70.24% |
| 2018 Q2 | 429.5 Million KRW | 41.69% |
| 2018 Q4 | 25.08 Million KRW | -80.37% |
| 2017 Q3 | 292.79 Million KRW | 490.36% |
| 2017 Q4 | 485.9 Million KRW | 65.95% |
| 2017 FY | 485.9 Million KRW | 104.81% |
| 2017 Q1 | 56.64 Million KRW | -76.12% |
| 2017 Q2 | 49.59 Million KRW | -12.44% |
| 2016 Q2 | 149.41 Million KRW | 167.84% |
| 2016 Q1 | 55.78 Million KRW | 49.06% |
| 2016 FY | 237.24 Million KRW | 533.94% |
| 2016 Q4 | 237.24 Million KRW | -36.99% |
| 2016 Q3 | 376.5 Million KRW | 151.99% |
| 2015 Q4 | 37.42 Million KRW | -6.87% |
| 2015 Q2 | 159.05 Million KRW | 143.21% |
| 2015 Q1 | 65.39 Million KRW | 0.0% |
| 2015 FY | 37.42 Million KRW | -74.45% |
| 2015 Q3 | 40.18 Million KRW | -74.74% |
| 2014 Q1 | - KRW | 0.0% |
| 2014 FY | 146.49 Million KRW | 386.71% |
| 2013 FY | 30.09 Million KRW | -8.34% |
| 2012 FY | 32.83 Million KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Co., Ltd. | 11.42 Billion KRW | 98.492% |
| iNtRON Biotechnology, Inc. | 1.01 Billion KRW | 82.97% |
| BINEX Co., Ltd. | 28.26 Billion KRW | 99.391% |
| Bioneer Corporation | 41.35 Billion KRW | 99.584% |
| Anterogen.Co.,Ltd. | 1.91 Billion KRW | 90.987% |
| MEDIPOST Co., Ltd. | 14.51 Billion KRW | 98.814% |
| CrystalGenomics, Inc. | 1.55 Billion USD | 88.925% |
| Helixmith Co., Ltd | 914.11 Million KRW | 81.163% |
| Chabiotech Co.,Ltd. | 34.11 Billion KRW | 99.495% |
| Medy-Tox Inc. | 59.61 Billion KRW | 99.711% |
| Amicogen, Inc. | 46.83 Billion KRW | 99.632% |
| Genexine, Inc. | 3.8 Billion KRW | 95.477% |
| HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | 96.773% |
| LegoChem Biosciences, Inc. | 196.83 Million KRW | 12.522% |
| ALTEOGEN Inc. | 1.06 Billion KRW | 83.883% |
| PharmaResearch Co., Ltd. | 50.23 Billion KRW | 99.657% |
| SillaJen, Inc. | 1.21 Billion KRW | 85.8% |
| JETEMA, Co., Ltd. | 12.74 Billion KRW | 98.649% |
| OliX Pharmaceuticals,Inc | 468.4 Million KRW | 63.24% |
| Genomictree Inc. | 496.53 Million KRW | 65.322% |
| MedPacto, Inc. | 620.00 KRW | -27772055.161% |
| D&D Pharmatech | 3.45 Billion KRW | 95.009% |
| EASY BIO,Inc. | 25.93 Billion KRW | 99.336% |
| GI Innovation, Inc. | - KRW | -Infinity% |